Overcoming barriers to SLT as first line therapy for POAG & OH – Prof. Gus GAZZARD
In this video, Prof. Gus GAZZARD , explains how to overcome barriers to SLT as first line therapy for POAG & OH. This video is from our symposium held at ESCRS 2023.
In this video, Prof. Gus GAZZARD , explains how to overcome barriers to SLT as first line therapy for POAG & OH. This video is from our symposium held at ESCRS 2023.
In this interview, Inder Paul Singh, MD, explains the interest of using SLT as first line therapy for glaucoma instead of medication and the impact on the ocular surface.
«SLT not only takes away the compliance issues that are so difficult for us but it actually addresses the pathology directly.»
Dr Paul Singh explains what type of patients can benefit from SLT to treat glaucoma.
Dr Franck Howes, Eye & Laser Centre Gold Coast (Australia) made a presentation on SLT (Selective Laser Trabeculoplasty) and detailed the process of applying laser energy for the control of glaucoma.
Quantel Medical y Ellex, dos marcas de Lumibird Medical, unidas con un objetivo: desarrollar tecnologías para el diagnóstico y tratamiento del ojo seco y las principales causas de ceguera en el mundo: glaucoma, cataratas, DMAE y retinopatía diabética.
"*" señala los campos obligatorios